RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
  Hearing Imapirment
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
ENT Channel

subscribe to ENT newsletter
Latest Research : ENT

   EMAIL   |   PRINT
Antibiotic telithromycin linked to liver damage

Jan 22, 2006 - 2:18:00 PM , Reviewed by: Priya Saxena
Telithromycin (Ketek) was approved by the US Food and Drug Administration in 2004.

 
[RxPG] An antibiotic drug to treat lung and sinus infections has been found to cause liver failure, according to a report.

Doctors at the Carolinas Medical Center in Charlotte, North Carolina, studied three patients who were administered the drug 'Ketek' and found liver failure in them, a report published in the journal Annals of Internal Medicine says.

All three cases occurred within a few months of each other last year, said report co-author John Hanson, a liver transplant doctor at the medical centre.

'Ketek' is prescribed to treat lung and sinus infections. The antibiotic also led to the death of a 26-year-old man and transplant surgery for a 51-year-old woman, it reported.

Ketek was approved by the US Food and Drug Administration in 2004. Doctors have sent their findings to the FDA and discussed them with Sanofi-Aventis SA, which makes Ketek.

The company is currently reviewing the data, the report said.



Publication: Indo-Asian News Service

Advertise in this space for $10 per month. Contact us today.


Related ENT News
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
$12 million for a center for research on aphasia
Mount Sinai awarded more than $5 million from NIH to study neurological voice disorder
Teaching the brain to speak again
Study to test whether hearing aids can help prevent falls
Speech-language researcher awarded top honors
A comparison of 2 home exercises to treat vertigo
Study compares traits of autism, schizophrenia
2-year-old children understand complex grammar
New polymer gel may restore vocal cords

Subscribe to ENT Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)